BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 18, 2006
View Archived Issues
Acologix Hopes To Bring In $115M On Tokyo Exchange
With Japanese investors holding the majority of its shares and a lead product in-licensed from a Tokyo-based company, Acologix Inc. filed to conduct a $115 million initial public offering on the Tokyo Stock Exchange. (BioWorld Today)
Read More
Biotechs Should Benefit When Leadership Atop FDA Finalized
Read More
Researchers Link P53 Tumor Suppressor To Angiogenesis
Read More
Accera's Alzheimer's Work Boosted By $7.5M Series B
Read More
Clinic Roundup
Read More
Other News To Note
Read More